Zobrazeno 1 - 10
of 1 419
pro vyhledávání: '"Michael, Drummond"'
Autor:
Sophie Staniszewska, Ivett Jakab, Eric Low, Jean Mossman, Phil Posner, Don Husereau, Richard Stephens, Michael Drummond
Publikováno v:
Research Involvement and Engagement, Vol 9, Iss 1, Pp 1-5 (2023)
Abstract Background Patient and public involvement in health economic evaluation is still relatively rare, compared to other areas of health and social care research. Developing stronger patient and public involvement in health economic evaluation wi
Externí odkaz:
https://doaj.org/article/a2eefb3d99a544cab789fdffa3523172
Autor:
Michael Drummond, Oriana Ciani, Giulia Fornaro, Claudio Jommi, Eva Susanne Dietrich, Jaime Espin, Jean Mossman, Gerard de Pouvourville
Publikováno v:
BMC Health Services Research, Vol 23, Iss 1, Pp 1-18 (2023)
Abstract Background The aims of this research were to provide a better understanding of the specific evidence needs for assessment of clinical and cost-effectiveness of cell and gene therapies, and to explore the extent that the relevant categories o
Externí odkaz:
https://doaj.org/article/7e742ed598834facb92c571d9c8ed8cc
Autor:
Don Husereau, Michael Drummond, Federico Augustovski, Esther de Bekker-Grob, Andrew H. Briggs, Chris Carswell, Lisa Caulley, Nathorn Chaiyakunapruk, Dan Greenberg, Elizabeth Loder, Josephine Mauskopf, C. Daniel Mullins, Stavros Petrou, Raoh-Fang Pwu, Sophie Staniszewska, on behalf of CHEERS 2022 ISPOR Good Research Practices Task Force
Publikováno v:
BMC Medicine, Vol 20, Iss 1, Pp 1-8 (2022)
Abstract Health economic evaluations are comparative analyses of alternative courses of action in terms of their costs and consequences. The Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement, published in 2013, was create
Externí odkaz:
https://doaj.org/article/d14a05412d2b4e1485c6f852a9a7e4d1
Autor:
Michele A. Kohli, Michael Maschio, Joaquin F. Mould-Quevedo, Michael Drummond, Milton C. Weinstein
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 17, Iss 11, Pp 4603-4610 (2021)
In the United Kingdom (UK), both the MF59-adjuvanted quadrivalent influenza vaccine (aQIV) and the high-dose QIV (QIV-HD) are preferred for persons aged 65 years and older but only aQIV is reimbursed by the National Health Service (NHS). The objectiv
Externí odkaz:
https://doaj.org/article/35b1566157c44197be5c7944183a51c6
Autor:
Francesco Ramponi, Pakwanja Twea, Benson Chilima, Dominic Nkhoma, Isabel Kazanga Chiumia, Gerald Manthalu, Joseph Mfutso-Bengo, Paul Revill, Michael Drummond, Mark Sculpher
Publikováno v:
Frontiers in Public Health, Vol 10 (2022)
Health technology assessment (HTA) offers a set of analytical tools to support health systems' decisions about resource allocation. Although there is increasing interest in these tools across the world, including in some middle-income countries, they
Externí odkaz:
https://doaj.org/article/e7d2262d03144ce58006f225ea7390b5
Publikováno v:
Cost Effectiveness and Resource Allocation, Vol 18, Iss 1, Pp 1-18 (2020)
Abstract Background This paper addresses the question of what a reasonable price for an orphan drug is. The research proposes a way to adjust an established payer/HTA body incremental cost-effectiveness threshold (CET) to take account of differences
Externí odkaz:
https://doaj.org/article/49a6b1cd109c41ba8d9db5e285b36b1c
Publikováno v:
Orphanet Journal of Rare Diseases, Vol 15, Iss 1, Pp 1-14 (2020)
Abstract Background There is increasing recognition that conventional appraisal approaches may be unsuitable for assessing the value rare disease treatments (RDTs). This research examines what supplemental appraisal/reimbursement processes for RDTs a
Externí odkaz:
https://doaj.org/article/1137457c7100465aa7b793aca2bc5141
Autor:
Manuela Di Fusco, Diana Mendes, Lotte Steuten, David E Bloom, Michael Drummond, Katharina Hauck, Jonathan Pearson-Stuttard, Rachel Power, David Salisbury, Adrian Towse, Julie Roiz, Gabor Szabo, Jingyan Yang, Kinga Marczell
Publikováno v:
Vaccines, Vol 11, Iss 2, p 234 (2023)
Health technology assessments (HTAs) of vaccines typically focus on the direct health benefits to individuals and healthcare systems. COVID-19 highlighted the widespread societal impact of infectious diseases and the value of vaccines in averting adv
Externí odkaz:
https://doaj.org/article/375388c809454e69b5885540cae44a98
Autor:
Andres Pichon-Riviere, Michael Drummond, Alfredo Palacios, Sebastián Garcia-Marti, Federico Augustovski
Publikováno v:
The Lancet Global Health. 11:e833-e842
Autor:
Rita Daubner-Bendes, Sándor Kovács, Maciej Niewada, Mirjana Huic, Michael Drummond, Oriana Ciani, Carl Rudolf Blankart, Olena Mandrik, Aleksandra Torbica, John Yfantopoulos, Guenka Petrova, Malwina Holownia-Voloskova, Rod S. Taylor, Maiwenn Al, Oresta Piniazhko, László Lorenzovici, Rosanna Tarricone, Antal Zemplényi, Zoltán Kaló
Publikováno v:
Frontiers in Public Health, Vol 8 (2021)
Objectives: Methodological challenges in the evaluation of medical devices (MDs) may be different for early and late technology adopter countries, as well as the potential health technology assessment (HTA) solutions to tackle them. This study aims t
Externí odkaz:
https://doaj.org/article/2fcee49fd2324bddad50714aa9e98040